Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
CNO Financial Group, Inc.
SIC 6321 · Accident & Health Insurance
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
CNO Financial Group, Inc.
SIC 6321 · Accident & Health Insurance
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
CNO Financial Group, Inc.
SIC 6321 · Accident & Health Insurance
Notes
Support
about
terms
$
CNO
CNO Financial Group, Inc.
CIK:
0001224608
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.26.1
CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)
shares in Thousands, $ in Millions
3 Months Ended
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenues:
Insurance policy income
$ 680.7
$ 651.3
$ 1,354.1
$ 1,302.0
Net investment income:
General account assets
411.9
378.3
806.9
753.4
Policyholder and other special-purpose portfolios
185.1
105.4
120.2
41.8
Investment losses:
Realized investment losses
(8.6)
(21.3)
(16.4)
(25.1)
Other investment gains (losses)
(6.1)
2.9
(21.0)
(0.1)
Total investment losses
(14.7)
(18.4)
(37.4)
(25.2)
Fee revenue and other income
22.2
34.9
71.0
83.6
Total revenues
1,285.2
1,151.5
2,314.8
2,155.6
Benefits and expenses:
Insurance policy benefits
742.5
658.4
1,319.1
1,228.4
Liability for future policy benefits remeasurement gain
(15.3)
(12.8)
(21.8)
(25.0)
Change in fair value of market risk benefits
(8.3)
(10.9)
2.4
4.4
Interest expense
55.3
59.1
106.2
121.1
Amortization of deferred acquisition costs and present value of future profits
74.9
68.6
149.1
136.0
Gain on extinguishment of borrowings related to variable interest entities
0.0
0.0
0.0
(1.5)
Other operating costs and expenses
276.4
271.1
551.7
546.4
Total benefits and expenses
1,125.5
1,033.5
2,106.7
2,009.8
Income before income taxes
159.7
118.0
208.1
145.8
Income tax expense
33.8
26.2
44.5
32.5
Net income
$ 125.9
$ 91.8
$ 163.6
$ 113.3
Basic:
Weighted average shares outstanding (in shares)
93,194
98,572
93,636
99,658
Net income (in dollars per share)
$ 1.35
$ 0.93
$ 1.75
$ 1.14
Diluted:
Weighted average shares outstanding (in shares)
94,952
100,386
95,545
101,728
Net income (in dollars per share)
$ 1.33
$ 0.91
$ 1.71
$ 1.11
v3.26.1
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:
Insurance policy income
$ 1,229.6
$ 1,182.4
Net investment income
772.6
748.2
Fee revenue and other income
96.1
98.5
Insurance policy benefits
(832.3)
(822.9)
Interest expense
(104.3)
(114.4)
Deferrable policy acquisition costs and sales inducements
(251.8)
(244.8)
Other operating costs
(583.5)
(564.5)
Income taxes
(21.0)
(0.3)
Net cash provided by operating activities
305.4
282.2
Cash flows from investing activities:
Sales of investments
6,499.8
1,716.9
Maturities and redemptions of investments
1,810.7
1,263.1
Purchases of investments
(9,088.3)
(3,631.2)
Other, net
(10.0)
(9.2)
Net cash used by investing activities
(787.8)
(660.4)
Cash flows from financing activities:
Payments on notes payable
0.0
(500.0)
Issuance of common stock
6.6
7.1
Payments to repurchase common stock
(134.2)
(210.6)
Common stock dividends paid
(33.8)
(33.6)
Payments on financing arrangements
(8.1)
(7.6)
Amounts received for deposit products
1,532.9
1,234.1
Withdrawals from deposit products
(1,058.5)
(1,402.1)
Issuance of investment borrowings:
Federal Home Loan Bank
776.8
526.8
Payments on investment borrowings:
Federal Home Loan Bank
(276.8)
(273.8)
Related to variable interest entities
0.0
(143.8)
Net cash provided (used) by financing activities
804.9
(803.5)
Net increase (decrease) in cash and cash equivalents
322.5
(1,181.7)
Cash and cash equivalents - unrestricted and including held by variable interest entities, beginning of period
983.5
1,997.7
Cash and cash equivalents - unrestricted and including held by variable interest entities, end of period
$ 1,306.0
$ 816.0
v3.26.1
CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Jun. 30, 2026
Dec. 31, 2025
Investments:
Fixed maturities, available for sale, at fair value (net of allowance for credit losses: June 30, 2026 - $41.5 and December 31, 2025 - $36.0; amortized cost: June 30, 2026 - $26,580.2 and December 31, 2025 - $25,776.4)
$ 24,495.7
$ 23,886.8
Equity securities at fair value
337.2
389.2
Mortgage loans (net of allowance for credit losses: June 30, 2026 - $17.0 and December 31, 2025 - $20.9)
3,356.3
3,256.8
Policy loans
144.2
140.9
Trading securities
258.6
294.8
Investments held by variable interest entities (net of allowance for credit losses: June 30, 2026 - $1.6 and December 31, 2025 - $0.6; amortized cost: June 30, 2026 - $296.2 and December 31, 2025 - $294.1)
292.3
293.0
Other invested assets
1,858.6
1,737.0
Total investments
30,742.9
29,998.5
Cash and cash equivalents - unrestricted
1,289.7
956.1
Cash and cash equivalents held by variable interest entities
16.3
27.4
Accrued investment income
302.5
286.0
Present value of future profits
135.5
143.6
Deferred acquisition costs and sales inducements
2,508.1
2,397.3
Reinsurance receivables (net of allowance for credit losses: June 30, 2026 - $1.0 and December 31, 2025 - $1.0)
3,568.5
3,677.5
Income tax assets, net
709.7
713.3
Assets held in separate accounts
3.0
2.8
Other assets
585.0
588.1
Total assets
39,861.2
38,790.6
Liabilities for insurance products:
Policyholder account balances
19,640.9
18,912.6
Future policy benefits
11,784.7
11,898.0
Market risk benefit liability
50.6
48.1
Liability for life insurance policy claims
61.8
58.4
Unearned and advanced premiums
219.0
228.0
Liabilities related to separate accounts
3.0
2.8
Other liabilities
957.1
952.8
Investment borrowings
2,941.7
2,441.7
Borrowings related to variable interest entities
274.5
274.4
Notes payable – direct corporate obligations
1,336.3
1,335.6
Total liabilities
37,269.6
36,152.4
Commitments and Contingencies (Note 14)
Shareholders' equity:
Common stock ($0.01 par value, 8,000,000,000 shares authorized, shares issued and outstanding: June 30, 2026 – 92,696,990; December 31, 2025 – 94,484,339)
0.9
0.9
Additional paid-in capital
1,227.4
1,336.3
Accumulated other comprehensive loss
(1,182.8)
(1,115.0)
Retained earnings
2,546.1
2,416.0
Total shareholders' equity
2,591.6
2,638.2
Total liabilities and shareholders' equity
$ 39,861.2
$ 38,790.6